Sfln 2020: The year a pandemic and politics collided in Wisconsin
MILWAUKEE 鈥?A traffic stop near 48th Capitol Monday afternoon escalated into a struggle in which a police officer was dragged by a car s driver, according to the Milwaukee Police Department.Milwaukee Police officers saw suspected illegal drugs in the car and ordered the driver to step out. The 33-year-old man driving the car began to drive the car. One officer got inside the vehicle but the other was dragged and fell off the car. The driver attempted to flee with one officer still in the car and crashed into two other vehicles near 55th and Capitol.Police arrested the driver and recovered the suspected illegal drugs. The 30-year-old male officer who was dragged in the struggl
stanley tumbler e was sent to the hospital to be treated for minor injuries. No other injuries were reported. Drivers going west on Capitol were re-routed at 54th. It was closed off for a block until about 55th.Acc
stanley cup ording to the Milwaukee Police Department, criminal charges will be referred to the Milwaukee County Distr
stanley mug ict Attorney s Office. Talk to us: Hey there! At TMJ4 News, were all about listening to our audience and tackling the stuff that really matters to you. Got a story idea, tip, or just want to chat about this piece Hit us up using the form below. For more ways to get in touch, head over to tmj4/tips. Its about time to watch on your time. Stream local news and weather 24/7 by searching for TMJ4 on your device.Available for download on Roku, Apple TV, Amazon F Vlkj Thousands wait along southern US border as end of Title 42 nears
SAN DIEGO 鈥?After the success of the mRNA COVID-19 vaccines made by Pfizer and Moderna, some San Diego-based companies are developing the next generation of the technology, called self-replicating RNA.Developers say it offers longer-lasting therapeutic effects than conventional RNA at lower doses.Arcturus Therapeutics is developing a self-replicating mRNA COVID-19 vaccine that just entered Phase 3 trials in Vietnam. The company is also testing its s
stanley cup hot as a third dose booster to the Pfizer vaccine in Singapore.A new San Diego-based startup called Replicate Bioscience is harnessing the technology to develop treatments for cancers and other non-infectious diseases. The company hopes to launch clinical trials next year.The COVID-19 vaccines from Pfizer and Moderna work by introducing strands of RNA instructions into cells, temporarily turning the cells into tiny drug factories. The cells churn out proteins to train the immune system, called antigens, for about two days before the factories shut down.Replicating RNA works in a similar way, but it directs the factories to make an additional
stanley kubek molecule. That molecule, an enzyme, fires the factory back up so it can keep production going for weeks or months.In the case of Arcturus, the c
stanley cup ompanys self-replicating COVID-19 vaccine prompts cells to produce immune-training proteins for about two weeks, said CEO Joe Payne. You need a vaccine that expresses the antigen for an extended period of time, so the body sees it, sees it again. Learns
